Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.

Lee HC, Narayanan S, Park SJ, Seong SY, Hahn YS.

J Biol Chem. 2014 Feb 21;289(8):5310-9. doi: 10.1074/jbc.M113.536102. Epub 2014 Jan 2. Erratum in: J Biol Chem. 2014 Apr 25;289(17):11861.

2.

Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.

Brownell J, Bruckner J, Wagoner J, Thomas E, Loo YM, Gale M Jr, Liang TJ, Polyak SJ.

J Virol. 2014 Feb;88(3):1582-90. doi: 10.1128/JVI.02007-13. Epub 2013 Nov 20.

3.

Hepatitis C virus NS3/4A protease blocks IL-28 production.

Ding Q, Huang B, Lu J, Liu YJ, Zhong J.

Eur J Immunol. 2012 Sep;42(9):2374-82. doi: 10.1002/eji.201242388.

4.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

5.

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.

Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, Rotman Y, Liang TJ.

Gastroenterology. 2012 Apr;142(4):978-88. doi: 10.1053/j.gastro.2011.12.055. Epub 2012 Jan 13.

6.

Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Ho W.

J Viral Hepat. 2013 Jun;20(6):385-94. doi: 10.1111/jvh.12040. Epub 2013 Jan 7.

7.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
8.

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.

Osterlund PI, Pietilä TE, Veckman V, Kotenko SV, Julkunen I.

J Immunol. 2007 Sep 15;179(6):3434-42.

9.

Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.

Yoshio S, Kanto T, Kuroda S, Matsubara T, Higashitani K, Kakita N, Ishida H, Hiramatsu N, Nagano H, Sugiyama M, Murata K, Fukuhara T, Matsuura Y, Hayashi N, Mizokami M, Takehara T.

Hepatology. 2013 May;57(5):1705-15. doi: 10.1002/hep.26182. Epub 2013 Mar 14.

PMID:
23213063
10.

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.

Diegelmann J, Beigel F, Zitzmann K, Kaul A, Göke B, Auernhammer CJ, Bartenschlager R, Diepolder HM, Brand S.

PLoS One. 2010 Dec 8;5(12):e15200. doi: 10.1371/journal.pone.0015200.

11.

IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.

Cao Y, Zhang R, Zhang W, Zhu C, Yu Y, Song Y, Wang Q, Bai L, Liu Y, Wu K, Wu J.

J Immunol. 2014 Jan 15;192(2):691-703. doi: 10.4049/jimmunol.1300252. Epub 2013 Dec 11.

12.

MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1.

Li Y, Xie J, Xu X, Wang J, Ao F, Wan Y, Zhu Y.

Protein Cell. 2013 Feb;4(2):130-41. doi: 10.1007/s13238-012-2081-y. Epub 2012 Nov 12.

PMID:
23150165
13.

MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.

Yang D, Meng X, Xue B, Liu N, Wang X, Zhu H.

PLoS One. 2014 Apr 11;9(4):e94501. doi: 10.1371/journal.pone.0094501. eCollection 2014.

14.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

15.

Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.

Paz S, Sun Q, Nakhaei P, Romieu-Mourez R, Goubau D, Julkunen I, Lin R, Hiscott J.

Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(1):17-28.

PMID:
16914100
16.

High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.

Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W.

J Virol. 2013 Sep;87(17):9707-18. doi: 10.1128/JVI.00802-13. Epub 2013 Jul 3.

17.

Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.

Brownell J, Wagoner J, Lovelace ES, Thirstrup D, Mohar I, Smith W, Giugliano S, Li K, Crispe IN, Rosen HR, Polyak SJ.

J Hepatol. 2013 Oct;59(4):701-8. doi: 10.1016/j.jhep.2013.06.001. Epub 2013 Jun 12.

18.

Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation.

Guitart A, Riezu-Boj JI, Elizalde E, Larrea E, Berasain C, Aldabe R, Civeira MP, Prieto J.

J Gen Virol. 2005 Nov;86(Pt 11):3065-74.

PMID:
16227229
19.

Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection.

Nakagawa S, Hirata Y, Kameyama T, Tokunaga Y, Nishito Y, Hirabayashi K, Yano J, Ochiya T, Tateno C, Tanaka Y, Mizokami M, Tsukiyama-Kohara K, Inoue K, Yoshiba M, Takaoka A, Kohara M.

PLoS One. 2013;8(3):e59611. doi: 10.1371/journal.pone.0059611. Epub 2013 Mar 28.

20.

Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.

Zekri AR, Moharram RA, Mohamed WS, Bahnassy AA, Alam El-Din HM, Abo-Shadi MM, Zayed NA, El-Magzangy H, Abdel-Aziz AO, Esmat G.

Eur J Gastroenterol Hepatol. 2010 Apr;22(4):450-6. doi: 10.1097/MEG.0b013e3283329d00.

PMID:
19858727
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk